科伦药业：第三季度实现归属于上市公司股东的净利润约2亿元

Group 1 - The core viewpoint of the article highlights that Kelun Pharmaceutical (SZ 002422) reported a significant decline in its financial performance for the third quarter, with a revenue of approximately 4.193 billion yuan, representing a year-on-year decrease of 15.48% [1] - The net profit attributable to shareholders of the listed company was around 200 million yuan, reflecting a substantial year-on-year decline of 70.18% [1] - The basic earnings per share were reported at 0.12 yuan, which is a decrease of 71.43% compared to the same period last year [1] Group 2 - As of the report, the market capitalization of Kelun Pharmaceutical stands at 54.7 billion yuan [1]